Corbus Pharmaceuticals Holdings, Inc. (CRBP)
11.21
-0.25
(-2.18%)
USD |
NASDAQ |
Sep 04, 14:21
Corbus Pharmaceuticals Holdings PS Ratio
PS Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical PS Ratio Data
| Date | Value |
|---|---|
| September 29, 2022 | 224.99 |
| September 28, 2022 | 228.34 |
| September 27, 2022 | 200.92 |
| September 26, 2022 | 205.94 |
| September 23, 2022 | 219.97 |
| September 22, 2022 | 231.68 |
| September 21, 2022 | 239.79 |
| September 20, 2022 | 238.25 |
| September 19, 2022 | 244.04 |
| September 16, 2022 | 267.08 |
| September 15, 2022 | 267.21 |
| September 14, 2022 | 264.50 |
| September 13, 2022 | 281.24 |
| September 12, 2022 | 277.76 |
| September 09, 2022 | 264.76 |
| September 08, 2022 | 256.14 |
| September 07, 2022 | 257.42 |
| September 06, 2022 | 250.47 |
| September 02, 2022 | 257.42 |
| September 01, 2022 | 248.67 |
| August 31, 2022 | 259.48 |
| August 30, 2022 | 263.86 |
| August 29, 2022 | 273.38 |
| August 26, 2022 | 275.06 |
| August 25, 2022 | 278.53 |
| Date | Value |
|---|---|
| August 24, 2022 | 276.73 |
| August 23, 2022 | 272.23 |
| August 22, 2022 | 272.87 |
| August 19, 2022 | 275.70 |
| August 18, 2022 | 285.10 |
| August 17, 2022 | 276.09 |
| August 16, 2022 | 314.06 |
| August 15, 2022 | 330.92 |
| August 12, 2022 | 330.40 |
| August 11, 2022 | 340.32 |
| August 10, 2022 | 328.34 |
| August 09, 2022 | 328.22 |
| August 08, 2022 | 343.66 |
| August 05, 2022 | 334.65 |
| August 04, 2022 | 344.56 |
| August 03, 2022 | 332.21 |
| August 02, 2022 | 327.19 |
| August 01, 2022 | 325.51 |
| July 29, 2022 | 325.90 |
| July 28, 2022 | 321.65 |
| July 27, 2022 | 341.34 |
| July 26, 2022 | 346.24 |
| July 25, 2022 | 361.94 |
| July 22, 2022 | 361.68 |
| July 21, 2022 | 378.29 |
Price to Sales Ratio Definition
The Price to Sales Ratio (PS Ratio) is calculated by taking the stock price / revenue per share (ttm). This metric is considered a valuation metric that confirms whether the sales of a company justifies the stock price. There isn't necesarily an optimum PS ratio, since different industries will have different ranges of PS Ratios. Because of this, PS Ratio is great to evaluate from a relative standpoint with other similar companies. PS Ratio might also be a handy metric for companies that are not profitable yet, since they might be valued moreso by their overall sales and potential of becoming profitable in the future.
PS Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
PS Ratio Benchmarks
| ACADIA Pharmaceuticals, Inc. | 4.228 |
| Alnylam Pharmaceuticals, Inc. | 7.580 |
| Anika Therapeutics, Inc. | 2.444 |
| Savara, Inc. | -- |
| Vericel Corp. | 6.755 |
PS Ratio Related Metrics
| PEG Ratio | -0.0612 |
| Price to Book Value | 2.047 |
| Price | 11.21 |
| Earnings Yield | -55.10% |
| Market Cap | 209.31M |
| PEGY Ratio | -0.0612 |